News from cardium therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 03, 2014, 09:00 ET
Taxus Cardium logo.  (PRNewsFoto/Cardium Therapeutics)

Cardium Announces Strategic Collaboration And Funding With Taxus Pharmaceuticals To Support Commercial Development Of Advanced Regenerative Therapeutics

 Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has entered into a strategic collaboration and funding arrangement with...

Jan 27, 2014, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings

 Cardium Therapeutics Inc. (Ticker Symbol: CRXM) reported on the Company's strategic focus on its two advanced regenerative medicine...

Jan 24, 2014, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Common Stock To Begin Trading On The OTCQB Market

 As previously reported, Cardium Therapeutics, an advanced regenerative therapeutics company, today announced that its common stock will begin...

Dec 31, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Cardium Therapeutics (NYSE MKT: CXM) today reported on advancements of the Company's two key biologics products, its Generx® candidate for...

Dec 20, 2013, 09:00 ET

Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing.  As previously reported, a communication from the staff...

Dec 04, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium's Excellagen Assigned Q Code For Product Reimbursement

 Cardium Therapeutics (NYSE MKT: CXM) today announced that Cardium's Excellagen®, a wound care product indicated for the treatment of...

Dec 03, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

LifeAgain's Bluemetric Select Life Insurance Now Offered At Lifequotes.com

 LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced that its BlueMetric...

Nov 19, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2013, and reported on recent...

Nov 18, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium's To Go Brands Acquired By Cell-nique And Healthy Brands Collective

Cardium Therapeutics (NYSE MKT: CXM) today announced that Cell-nique Corporation, which owns a variety of innovative businesses that are part of...

Nov 08, 2013, 09:00 ET

Cardium Announces Publication On Use Of Excellagen For Managing Chronic Pressure Ulcers In Elderly Patients

Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of a case study, "Serial Sharp Debridement and Formulated Collagen Gel to...

Oct 07, 2013, 10:27 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing.  As previously reported, a communication from the...

Sep 27, 2013, 15:54 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Unusual Trading Activity In Cardium Common Stock

Cardium Therapeutics (NYSE MKT: CXM) today released the following statement. In view of the unusual market activity in the Company's common...

Sep 20, 2013, 09:00 ET
LifeAgain Logo.  (PRNewsFoto/LifeAgain)

LifeAgain Announces Recognition Of National Prostate Cancer Awareness Month

 LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced its recognition of...

Sep 19, 2013, 09:00 ET
LifeAgain Logo.  (PRNewsFoto/LifeAgain)

LifeAgain Supports Life Insurance Awareness Month

 LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced its support of Life...

Sep 16, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium's LifeAgain Launches First Life Insurance Program Developed For Men With Active Localized Prostate Cancer

 Cardium Therapeutics (NYSE MKT: CXM) today announced that LifeAgain™ Insurance Solutions Inc., a wholly-owned subsidiary in Cardium's...

Aug 26, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium's LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology

 Cardium Therapeutics (NYSE MKT: CXM) today announced that its LifeAgain™ Insurance Solutions Inc., a wholly-owned subsidiary in...

Aug 14, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Reports On Second Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the second quarter ended June 30, 2013, and reported on recent...

Aug 12, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells

Cardium Therapeutics (NYSE MKT: CXM) today reported on a research collaboration with researchers at Boston Children's Hospital, to assess the...

Aug 07, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Announces Excellagen Distribution Agreement With Kasiak For Germany And Switzerland

 Cardium Therapeutics (NYSE MKT: CXM) today announced that it has entered into a distribution agreement with Kasiak Holdings AG for the...

Aug 06, 2013, 09:00 ET
Logo. (PRNewsFoto/Cardium Therapeutics)

Cardium Reports On New Excellagen-Based Stromal Cell Research For Wound Healing With Orbsen Therapeutics Under European FP7 REDDSTAR Diabetes Initiative

Cardium Therapeutics (NYSE MKT: CXM) today announced that it has entered into an agreement with Orbsen Therapeutics Ltd and the National...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge